Appropriate Use Criteria for 18 F-Floretyrosine (FET) PET Imaging in Patients with Primary Brain Tumors
Year: 2026
Type: article
Source: Journal of Nuclear Medicine
Authors: Derek R. Johnson, Nathalie L. Albert, William G. Breen, Shawn L. Hervey-Jumper, Raymond Y. Huang, Jana Ivanidze, Michelle M. Kim, Jonathan E. McConathy, Nancy Ann Oberheim Bush, Ian F. Parney, Matthias Preusser, Roger Stupp, Erik P. Sulman, Michael C. Veronesi, Javier E. Villanueva-Meyer, Thomas A. Hope
Institutions: Mayo Clinic, LMU Klinikum, Ludwig-Maximilians-Universität München, University of California, San Francisco, Harvard University, Mass General Brigham, Weill Cornell Medicine, University of Michigan, McMaster University, Medical University of Vienna, Northwestern University, Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Duke University, Duke Medical Center, University of Wisconsin–Madison
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7225915248
